Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for PODD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -9.00M
March 31, 2026 299.60M
December 31, 2025 -9.60M
September 30, 2025 24.90M
June 30, 2025 36.00M
March 31, 2025 -25.60M
December 31, 2024 -6.40M
September 30, 2024 -0.80M
June 30, 2024 -7.10M
March 31, 2024 -5.80M
December 31, 2023 -9.00M
September 30, 2023 -0.10M
June 30, 2023 -11.80M
March 31, 2023 -6.00M
December 31, 2022 -7.10M
September 30, 2022 -2.40M
June 30, 2022 -5.70M
March 31, 2022 -1.10M
December 31, 2021 -9.10M
September 30, 2021 -4.40M
June 30, 2021 -8.50M
March 31, 2021 -1.50M
December 31, 2020 -6.90M
September 30, 2020 -10.60M
June 30, 2020 -485.50M
Date Value
March 31, 2020 -6.20M
December 31, 2019 77.44M
September 30, 2019 -17.26M
June 30, 2019 -16.63M
March 31, 2019 -9.061M
December 31, 2018 -16.20M
September 30, 2018 -1.103M
June 30, 2018 4.446M
March 31, 2018 -2.961M
December 31, 2017 -5.069M
September 30, 2017 -2.844M
June 30, 2017 -1.556M
March 31, 2017 -6.335M
December 31, 2016 -0.006M
September 30, 2016 -3.358M
June 30, 2016 -0.694M
March 31, 2016 -0.796M
December 31, 2015 -0.808M
September 30, 2015 -0.554M
June 30, 2015 -1.613M
March 31, 2015 -4.876M
December 31, 2014 -4.709M
September 30, 2014 -1.538M
June 30, 2014 -1.778M
March 31, 2014 -3.561M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 1.042B
DexCom, Inc. 603.60M
Boston Scientific Corp. 1.995B
PROCEPT BioRobotics Corp. -4.496M
Globus Medical, Inc. 125.09M